These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1687774)

  • 1. Hypotensive and regional hemodynamic effects of the dopamine receptor agonist SK & F 85174 in the anesthetized rat.
    Van der Niepen P; Schoors DF; Dupont AG
    Arch Int Pharmacodyn Ther; 1991; 313():98-107. PubMed ID: 1687774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.
    Lappe RW; Todt JA; Wendt RL
    J Pharmacol Exp Ther; 1986 Jan; 236(1):187-91. PubMed ID: 2867214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurogenic vasodilatation produced by fenoldopam in the rat hindquarters vascular bed.
    Van der Niepen P; Lefebvre RA; Dupont AG
    J Auton Pharmacol; 1987 Dec; 7(4):331-8. PubMed ID: 2895108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog.
    Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1990; 2(4):219-25. PubMed ID: 1982058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
    Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive and regional haemodynamic effects of fenoldopam and quinpirole in the anaesthetized rat.
    Van der Niepen P; Dupont AG; Finne E; Six RO
    J Hypertens Suppl; 1988 Dec; 6(4):S687-9. PubMed ID: 2907350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
    Hom GJ; Jandhyala BS
    J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
    Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb.
    Lokhandwala MF; Watkins HO; Dlewati A
    Eur J Pharmacol; 1987 Nov; 143(3):383-90. PubMed ID: 2891555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential usefulness of renal vasodilators in hypertension and renal disease: SK&F 82526.
    Ackerman DM; Blumberg AL; McCafferty JP; Sherman SS; Weinstock J; Kaiser C; Berkowitz B
    Fed Proc; 1983 Feb; 42(2):186-90. PubMed ID: 6130004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of SK&F 82526 and SK&F 83742 on the renal vascular dopamine receptor.
    Schmidt M; Imbs JL; Giesen-Crouse EM; Schwartz J
    J Pharmacol; 1985; 16(1):15-22. PubMed ID: 2582206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
    Hahn RA; MacDonald BR
    J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Do renal vascular D2 receptors exist?].
    Barthelmebs M; Krieger JP; Grima M; Imbs JL
    Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1211-3. PubMed ID: 1953269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional hemodynamic effects of purinergic P2 receptor subtype agonists in rats.
    Cox BF; Smits GJ
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1492-500. PubMed ID: 8667215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.